Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes

OBJECTIVE: Diabetes has emerged as an important risk factor for mortality from COVID-19. Metformin, the most commonly prescribed glucose-lowering agent, has been proposed to influence susceptibility to and outcomes of COVID-19 via multiple mechanisms. We investigated whether, in patients with diabet...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Endocrinol Metab
Egile Nagusiak: Wang, Jingya, Cooper, Jennifer M, Gokhale, Krishna, Acosta-Mena, Dionisio, Dhalla, Samir, Byne, Nathan, Chandan, Joht Singh, Anand, Astha, Okoth, Kelvin, Subramanian, Anuradhaa, Bangash, Mansoor N, Jackson, Thomas, Zemedikun, Dawit, Taverner, Tom, Hanif, Wasim, Ghosh, Sandip, Narendran, Parth, Toulis, Konstantinos A, Tahrani, Abd A, Surenthirakumaran, Rajendra, Adderley, Nicola J, Haroon, Shamil, Khunti, Kamlesh, Sainsbury, Christopher, Thomas, G Neil, Nirantharakumar, Krishnarajah
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2021
Gaiak:
Clinical Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7928949/
https://ncbi.nlm.nih.gov/pubmed/33560344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgab067
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak